Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.Leukemia & Lymphoma|January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's diseaseJ Fleury, M Legros, P Colombat, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2005
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trialB P Coudert, L Arnould, L Moreau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up durationJ L Misset, M di Palma, M Delgado, et al.Breast Cancer Research and Treatment|November 27, 2004
Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use programJ Y Pierga, P Fumoleau, Y Brewer, et al.European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experienceJ Bonneterre, M Spielman, J P Guastalla, et al.British Journal of Cancer|May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trialP Kerbrat, H Roché, J Bonneterre, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerS Giacchetti, B Perpoint, R Zidani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.Pageof 18